glp-1 usage statistics Use Has More Than Quadrupled Since 2021 as Obesity Rates Continue to Show Signs of Decline GLP-1 Trends: Costs & Coverage

Dysdigestion: Dysdigestion is characterized by discomfort in the upper abdomen, a feeling of fullness, belching, and other symptoms

In 2024, Ahmad and Sabbour conducted a meta-analysis encompassing data from over 110,000 patients, encompassing 13 investigations that evaluated the combined use of GLP-1 RAs and SGLT-2 inhibitors

Regulatory Compliance GLP-1 medications are subject to strict global standards, including: FDA (USA): Vaccines should be kept in validated storage with continuous monitoring between +2 C and +8 C EMA (Europe): Good Distribution Practice (GDP) requiring calibrated, validated equipment

AI Meal Tracking

Nature 409:307312